Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD Moderna, Inc. Transaction History
Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD
- $356 Million
- Q2 2024
A detailed history of Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD holds 18,863 shares of MRNA stock, worth $1.26 Million. This represents 0.63% of its overall portfolio holdings.
Number of Shares
18,863
Previous 32,188
41.4%
Holding current value
$1.26 Million
Previous $3.43 Million
34.7%
% of portfolio
0.63%
Previous 0.92%
Shares
4 transactions
Others Institutions Holding MRNA
# of Institutions
1,114Shares Held
241MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO43.4MShares$2.9 Billion4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$2.64 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.71 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$1 Billion0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$483 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $26.1B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...